Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
47,970,593
-
Total 13F shares
-
38,161,776
-
Share change
-
-231,286
-
Total reported value
-
$694,539,798
-
Put/Call ratio
-
8.2%
-
Price per share
-
$18.20
-
Number of holders
-
160
-
Value change
-
-$10,679,652
-
Number of buys
-
70
-
Number of sells
-
73
Institutional Holders of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) as of Q4 2022
As of 31 Dec 2022 BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) had 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,161,776 shares of stock of the company.
Largest 10 holders included Casdin Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, FRED ALGER MANAGEMENT, LLC, GENEVA CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, STATE STREET CORP, PALISADE CAPITAL MANAGEMENT, LP, JENNISON ASSOCIATES LLC, and Park West Asset Management LLC.
This table shows 160 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.